Severe acute motor neuropathy after treatment with triple tyrosine kinase inhibitor BIBF 1120 (Nintedanib). - Patejdl, R.; Markmann, S.; Benecke, R.; Wittstock, M. (Clinical Neurology & Neurosurgery, 2013)